BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1606550)

  • 1. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
    Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
    Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents.
    Cuneo A; Fagioli F; Pazzi I; Tallarico A; Previati R; Piva N; Carli MG; Balboni M; Castoldi G
    Leuk Res; 1992 Aug; 16(8):789-96. PubMed ID: 1528067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
    Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
    Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia].
    Wang D; Ke XY; Wang J; Xu F; Hu YF
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1384-8. PubMed ID: 17785057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.
    Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T
    Blood; 2003 Oct; 102(7):2395-402. PubMed ID: 12805060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras oncogene activation and occupational exposures in acute myeloid leukemia.
    Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
    J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features.
    Fagioli F; Cuneo A; Carli MG; Bardi A; Piva N; Previati R; Rigolin GM; Ferrari L; Spanedda R; Castoldi G
    Cancer Genet Cytogenet; 1993 Dec; 71(2):119-24. PubMed ID: 7506635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Bigoni R; Piva N; Minotto C; Agostini P; De Angeli C; Del Senno L; Spanedda R; Castoldi G
    Br J Haematol; 1998 Oct; 103(1):189-97. PubMed ID: 9792307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
    Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
    Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents.
    Albin M; Björk J; Welinder H; Tinnerberg H; Mauritzson N; Johansson B; Billström R; Strömberg U; Mikoczy Z; Ahlgren T; Nilsson PG; Mitelman F; Hagmar L
    Scand J Work Environ Health; 2000 Dec; 26(6):482-91. PubMed ID: 11201395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study.
    Ciccone G; Mirabelli D; Levis A; Gavarotti P; Rege-Cambrin G; Davico L; Vineis P
    Cancer Genet Cytogenet; 1993 Jul; 68(2):135-9. PubMed ID: 8353805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells.
    Vinante F; Rigo A; Vincenzi C; Ricetti MM; Marrocchella R; Chilosi M; Cassatella MA; Bonazzi L; Pizzolo G
    Leukemia; 1993 Oct; 7(10):1552-6. PubMed ID: 8412317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.